Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products.

Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.

Life Sciences

Pharmaceutical

Evidera

Jon Williams

Tracy Farrow

Malinda O'Donnell

Elizabeth Froom

Kelly Ferrell

Derek Phillips

Robert Dew

Kenneth Ferentz

Sonja M. Stringer Pmp, Mph

Monica Hadi

Karen Sandman

Thomas Baker

Foster Rockwell

Sebastian Heidenreich

Jaime Caro

The Market Access Writers Team at Evidera specializes in creating compelling, evidence-based content to support the market access and commercialization of biopharmaceutical and biotechnology products. This team develops detailed reports, health economic manuscripts, payer communication materials, and value dossiers to demonstrate the real-world effectiveness, safety, and economic value of products, ultimately aiding in their optimal market entry and reimbursement success.

Market Access Writers Team

Research and Analytics Team

Project Management Team

Market Access Writers Team

About

Team members

Other teams at Evidera

Research and Analytics Team

Project Management Team